According to our latest study on "Cell Line Development Market Forecast to 2027 – COVID-19 Impact and Analysis by Type, Product, and Application," the market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027. The report highlights trends prevailing in the global cell line development market, and the drivers and restraints pertaining to the market growth.
The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of therapeutic recombinant proteins. However, the hybridomas segment is estimated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics.
The following manufacturers are covered: Thermo Fisher Scientific Inc., Merck KGaA, Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., WuXi AppTec Group and more
Request a sample copy of this report @ https://www.theinsightpartners.com/sample/TIPHE100001196/
Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies.
Geographically, the Cell Line Development market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM).
The Report Segments Global Cell Line Development Market as Follows:
- Primary Cell Line
- Continuous Cell Lines
- Recombinant Cell Line
- Media & Reagent
- Drug Discovery
- Tissue Engineering
Key Elements that the report acknowledges:
- Market size and growth rate during forecast period.
- Key factors driving the “Cell Line Development” market.
- Key market trends cracking up the growth of the “Cell Line Development” market.
- Challenges to market growth.
- Key vendors of “Cell Line Development” market.
- Detailed SWOT analysis.
- Opportunities and threats faces by the existing vendors in Global “Cell Line Development” market.
- Trending factors influencing the market in the geographical regions.
- Strategic initiatives focusing the leading vendors.
- PEST analysis of the market in the five major regions.
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Cell Line Development, Cell Line Development Market, Cell Line Development Market Analysis